SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotify shares are drawing attention after rising sharply despite a Q3 revenue and EPS miss, with traders focusing instead on premium subscriber growth, stronger gross margin, and an upbeat Q4 operating-income outlook. The move has surprised skeptics, while bullish traders point to the guidance and operating metrics as support for the rally.

Compound (COMP) is a cryptocurrency and operates on the Ethereum platform. Compound has a current supply of 10,000,000 with 9,999,999.99995246 in circulation. The last known price of Compound is 20.49527411 USD and is down -2.02 over the last 24 hours. It is currently trading on 652 active market(s) with $25,001,434.49 traded over the last 24 hours. More information can be found at https://www.compound.xyz/.

Compound

Discussion centers on Compounds institutional push, including its institutional-market launch, new leadership, and plans tied to tokenized assets and DeFi. Traders see these developments as potential growth drivers, while others remain frustrated that COMP has lagged broader crypto and struggled to sustain gains.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings beat, supported by growth in Dupixent and Eylea HD, is driving a sharp share-price gain and breakout discussion. Traders are broadly bullish on the follow-through and new highs, while some are watching for a pullback or gap retest.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHDs strong performance and fresh highs are drawing attention as traders describe a rotation from volatile tech and AI stocks into dividend-paying value funds for defensive exposure. Long-term holders are celebrating and adding shares, while some caution the rally may be stretched and note that rising Treasury yields can pressure dividend ETFs.

Interactive Brokers Group, Inc. is an investment holding company, which engages in broker or dealer and proprietary trading businesses. It offers custody and service accounts for hedge and mutual funds, exchange-traded funds, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. The company was founded by Thomas Pechy Peterffy in 1977 and is headquartered in Greenwich, CT.

Interactive Brokers Group Inc - Ordinary Shares - Class A

Interactive Brokers Group Inc 

IBKR is drawing attention after its earnings report prompted a selloff despite growth in client accounts and interest income; traders are focused on weaker trading activity and competition, while others view the firms profitability and dividend increase as positives. The reaction reflects debate over whether slower activity outweighs the companys strong underlying business.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing treatment for recurrent respiratory papillomatosis has put pressure on Precigens PAPZIMEOS and sparked debate over how much competition it will bring. Traders weigh Inovios potential treatment advantages against Precigens commercial head start and full-approval status, while questioning the rivals accelerated-approval and commercialization path.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Shares are under pressure after Schwabs Q3 revenue fell slightly short of estimates despite an earnings beat, with traders focused on whether the prolonged decline can hold near $84. Some see an oversold buying opportunity, while others remain concerned about continued weakness and recurring platform outages.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVies stronger-than-expected third-quarter results and raised 2026 outlook, supported by growth in its immunology portfolio, are driving attention. Traders are weighing the earnings beat against the stocks recent run-up, with some cheering the results and others describing the reaction as profit-taking or sell the news.

NEOS ETF Trust - NEOS Nasdaq 100 High Income ETF

NEOS Nasdaq 100 High Income ETF

A broader market and technology-stock selloff is weighing on QQQI, prompting many income-focused traders to buy the dip while others are moving to cash or questioning the funds downside and NAV risks. The discussion also centers on its monthly option-income distributions and the trade-off between cash flow and capped upside.

Carpenter Technology Corp. engages in the manufacturing, fabrication, and distribution of specialty metals. It operates through the Specialty Alloys Operations and Performance Engineered Products segments. The Specialty Alloys Operations segment is composed of its major premium alloy and stainless-steel manufacturing operations. The Performance Engineered Products segment includes the Dynamet titanium, Carpenter Additive, and the Latrobe and Mexico distribution businesses. The company was founded by James Carpenter in 1889 and is headquartered in Philadelphia, PA.

Carpenter Technology Corp.

Carpenter Technologys latest quarterly report has sparked a sharp selloff despite profit coming in above expectations: revenue missed, the full-year outlook was maintained, and higher capital spending weighed on free cash flow. Bulls call the drop an oversold reaction to strong aerospace and defense demand, while bears focus on the cautious outlook and cash-flow pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HubSpot (HUBS) Earnings Expected to Grow: Should You Buy?

HubSpot (HUBS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Procore Technologies (PCOR) Earnings Expected to Grow: Should You Buy?

Procore Technologies (PCOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Procore Launches Voice-First AI Mobile App Built for the Jobsite

Today at Groundbreak 2026, Procore Technologies, Inc. (NYSE: PCOR), the leading global provider of construction management software, launched Procore AI Go, a voice-first mobile app that lets construction crews ask questions and receive instant, spoken answers from their project data within...

Procore Collaborates with NVIDIA to Deliver Advanced Digital Twin Capabilities to Predict and Minimize Risks for Megaprojects

Today at Groundbreak 2026, Procore Technologies, Inc. (NYSE: PCOR), the leading global provider of construction management software, announced the next phase of its collaboration with NVIDIA, bringing advanced digital twin capabilities to complex construction projects. Currently in closed beta...

Procore Announces Collaboration with IBM Focused on Enhancing Asset Lifecycle Management for Capital Project Owners and Operators

Today at Groundbreak 2026, Procore Technologies, Inc. (NYSE: PCOR), the leading global provider of construction management software, announced it is collaborating with IBM to enhance asset lifecycle management for owners by connecting Procore and IBM Maximo Application Suite, IBM's enterprise asset...

Procore Names COMPASS Its Preferred Subcontractor Prequalification Solution

Procore Names COMPASS Its Preferred Subcontractor Prequalification Solution Procore Names COMPASS Its Preferred Subcontractor Prequalification SolutionPR NewswireTORONTO, Oct. 15, 2026Prequal for All Gives Risk Teams and Project Teams One Source of Subcontractor RiskTORONTO, Oct. 15, 2026...

Procore Announces Timing of Third Quarter Fiscal Year 2026 Earnings Call

Procore Technologies, Inc. (NYSE: PCOR), the leading global provider of construction management software, today announced that it will report its third quarter fiscal year 2026 financial results after the U.S. financial markets close on Tuesday, November 3, 2026. In conjunction with this...

Meta Platforms (META) Moves 11.3% Higher: Will This Strength Last?

Meta Platforms (META) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Procore Technologies (PCOR) Upgraded to Buy: Here's Why

Procore Technologies (PCOR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Procore Introduces Asset Register Within Asset Management to Simplify Handover from Contractor to Owner

Procore Technologies, Inc. (NYSE: PCOR), the leading global provider of construction management software, today announced the general availability of Asset Register, a new tool within Procore Asset Management that helps contractors replace weeks of project handoff work with a continuous digital...

Procore Technologies, Inc. engages in the provision of cloud-based construction management software. It focuses on connecting and empowering the construction industry’s key stakeholders, such as owners, general contractors, and specialty contractors, to collaborate and access capabilities from any location on any internet-connected device. The company was founded by Craig F. Courtemanche, Jr. and Steven C. Zahm in 2002 and is headquartered in Carpinteria, CA.

Procore Technologies Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$61.38
Prev Close	$61.12
Open	$61.29
Dividend Yield	0.00%
50-Day Moving Average	$56.68
Beta	1.40
Avg. Volume	2.63M
PE Ratio	-236.99

52-Week High	$82.32
52-Week Low	$38.03
Market Capitalization	$9.33B
EPS (Annual)	-$0.6708
Price to Book	7.29
Revenue Per Employee	$299,142.50

Feed

News

Sentiment

Earnings

Fundamentals

Info

PCOR Fundamentals